Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma

Sieghart, Wolfgang; Pinter, Matthias; Dauser, Bernhard; Rohr-Udilova, Natalya; Piguet, Anne-Christine; Prager, Gerald; Hayden, Hubert; Dienes, Hans-Peter; Dufour, Jean-François; Peck-Radosavljevic, Markus (2012). Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma. Journal of hepatology, 57(3), pp. 592-9. Amsterdam: Elsevier 10.1016/j.jhep.2012.04.034

Full text not available from this repository. (Request a copy)

The combination of erlotinib with sorafenib is currently being investigated in a phase III RCT. We studied the effect of erlotinib and sorafenib on HCC in a preclinical model.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie

UniBE Contributor:

Dufour, Jean-François

ISSN:

0168-8278

Publisher:

Elsevier

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:38

Last Modified:

10 Oct 2016 19:56

Publisher DOI:

10.1016/j.jhep.2012.04.034

PubMed ID:

22634341

Web of Science ID:

000307933100020

URI:

https://boris.unibe.ch/id/eprint/15206 (FactScience: 222498)

Actions (login required)

Edit item Edit item
Provide Feedback